SynthesisBMC infectious diseases2024
Agent-based modelling of Mycobacterium tuberculosis transmission: a systematic review.
Synthesis in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A generalized SEIRW-VN framework for modeling infectious disease dynamics.Scientific reports · 2026Article
- Case Report: Epidemiologically inferred reverse zoonosis and intra-household zoonotic re-exposure ofFrontiers in veterinary science · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
Abstract
backgroundTraditional epidemiological models tend to oversimplify the transmission dynamics of Mycobacterium tuberculosis (M.tb) to replicate observed tuberculosis (TB) epidemic patterns. This has led to growing interest in advanced methodologies like agent-based modelling (ABM), which can more accurately represent the complex heterogeneity of TB transmission.
objectivesTo better understand the use of agent-based models (ABMs) in this context, we conducted a systematic review with two main objectives: (1) to examine how ABMs have been employed to model the intricate heterogeneity of M.tb transmission, and (2) to identify the challenges and opportunities associated with implementing ABMs for M.tb. SEARCH
methodsWe conducted a systematic search following PRISMA guidelines across four databases (MEDLINE, EMBASE, Global Health, and Scopus), limiting our review to peer-reviewed articles published in English up to December 2022. Data were extracted by two investigators using a standardized extraction tool. Prospero registration: CRD42022380580. SELECTION CRITERIA: Our review included peer-reviewed articles in English that implement agent-based, individual-based, or microsimulation models of M.tb transmission. Models focusing solely on in-vitro or within-host dynamics were excluded. Data extraction targeted the methodological, epidemiological, and computational characteristics of ABMs used for TB transmission. A risk of bias assessment was not conducted as the review synthesized modelling studies without pooling epidemiological data.
resultsOur search initially identified 5,077 studies, from which we ultimately included 26 in our final review after exclusions. These studies varied in population settings, time horizons, and model complexity. While many incorporated population heterogeneity and household structures, some lacked essential features like spatial structures or economic evaluations. Only eight studies provided publicly accessible code, highlighting the need for improved transparency. AUTHORS'
conclusionsABMs are a versatile approach for representing complex disease dynamics, particularly in cases like TB, where they address heterogeneous mixing and household transmission often overlooked by traditional models. However, their advanced capabilities come with challenges, including those arising from their stochastic nature, such as parameter tuning and high computational expense. To improve transparency and reproducibility, open-source code sharing, and standardised reporting are recommended to enhance ABM reliability in studying epidemiologically complex diseases like TB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.